We surveyed the occurrence of toxigenic cyanobacteria, the mcyA component of the microcystin synthetase gene and microcystin in aquatic systems in temperate Australia and tropical Thailand.
assays such as enzyme linked immunosorbent assay (ELISA) and protein phosphatase inhibition (PPi) with high performance liquid chromatography (HPLC) for detection of microcystin (Fastner et al. 2002; Rapala et al. 2002) . The use of PCR-based genetic methods for screening environmental water samples has been very limited to date (Baker et al. 2001; Bittencourt-Oliveira 2003) .
This paper assesses the performance of emerging analytical methods for the measurement of the public health risk from microcystin that are available to water and public health authorities. The methods were ranked on cost, reliability and simplicity in a routine laboratory setting to provide a pragmatic assessment, relevant to the water industry. methods used in the survey are described briefly here; a more detailed review is available in Chorus & Bartram (1999) .
METHODS
As a test of the reproducibility of the biochemical analyses, sub-samples of a microcystin producing strain of Microcystis (PCC7806) were prepared and stored frozen, then submitted with different sample batches to the respective analytical laboratories.
Microscopy
The method consisted of conventional light microscopy with 10 times sample concentration, mild sonication to disrupt colonies, Lugols fixation and 20 h sedimentation.
The method detection limit was 10 cells ml 21 for each cyanobacterial species after sonication. Microscopic examination cannot detect microcystin but can identify the presence of toxigenic cyanobacteria (i.e. species with the potential to produce cyanotoxins). The estimated cost for each test (excluding labour) was US$1.50 and the labour time was 50 minutes per test.
Protein phosphatase inhibition (PPi)
The colorimetric protein phosphatase inhibition assay was based on the method described by Heresztyn & Nicholson (2001) . Protein phosphatase PP2A was purchased from Promega Corporation, Australia. It was supplied in lots of 25 units, one unit being defined as the amount of enzyme required to hydrolyse one nanomole of pNPP min 21 at 308C under the specified assay conditions (Promega Technical Bulletin 537). The IC 50 was between 0.4 and 0.8 ug l 21 (microcystin -LR equivalents) and the response range was 0.3-1 ug l 21 . Each sample was always tested in duplicate and the mean of the two results was reported. The PPi method is not specific for microcystin, as the phosphatase enzyme can be inhibited by other compounds that occur in environmental samples. All reagents are commercially available and the estimated cost of each test (excluding labour) was US$15. The labour time for an analytical run was 4 -6 person hours depending on the number of tests.
The laboratory's usual practice was to analyse a maximum of 12 samples in a single run, which equates to 4 hours for one test or 30 minutes per test if 12 samples are analysed.
Enzyme-linked immunosorbent assay (ELISA)
The method was an indirect ELISA, sensitive to the ADDA moiety of microcystin as described in Fischer et al. (2001) .
We used Abraxis antibody to screen for microcystins. All samples were run (in triplicate) on plates coated with antibody in-house. Normal variability between replicates was no more than 5%. These were then averaged. Both the ELISA and the PPi methods have low limits of detection, so sample pre-concentration is not required.
These tests have a limited linear response to microcystins, within a narrow range (0.2 -10 ug l 21 ). Sample concentrations above the linear range were diluted to give semiquantitative results.
The inhibitory power of different analogues of microcystin to the phosphatase enzyme PP2A used in the PPi assay reflects how tight the binding forces are between the enzyme and its inhibitor. This to some extent reflects the toxicity. The only known crystal structure for a phosphatase enzyme with bound inhibitor, PP1 and Mic-LR, was described by Goldberg et al. (1995) . That structure suggests that the different structural analogues of microcystin will have different interactions between the inhibitor and the phosphatase enzyme, leading to different inhibitory power, which in turn should be a measure of toxicity.
The ELISA ideally should show no cross reactivity.
However, the EnTox laboratory has observed favourable interactions between microcystin and the antibody, when the arginine position is occupied by a relatively small side chain (as in Mic-LA and Mic-L-Aba). This difference in reactivity caused these microcystin analogues to be overestimated compared with Mic-LR. Both the PPi and the ELISA assays were calibrated using microcystin-LR and all results were expressed as microcystin-LR equivalents.
Polymerase chain reaction (PCR)
The PCR test for the mcyA gene only determines presence or absence of this DNA fragment. In this study, the PCR test amplified mcyA DNA when 10 or more cells were present and there was no inhibition. Water samples (100 ml) were concentrated by centrifugation, then the DNA was extracted and 1% of the extract (1 ml) was used for the test. This concentration and dilution process gave a theoretical detection limit of 10 mcyA containing cells per ml. The PCR method was highly specific for the presence of A detection limit of 0.2 ug l 21 for individual microcystins is achievable by this method. If more than one microcystin is present the reporting limit for the method is 0.5 mg l 21 total microcystins. The HPLC method takes about 3.5 hours for each analysis because concentration and chromatography cannot be run in parallel, although automation can speed up the processing. Analyses by HPLC were not replicated.
The estimated cost for each sample (excluding labour) was US$50.
Recovery
The recovery of microcystin in all tests was assessed by inclusion of internal standards. The results of the PPi and ELISA tests were rejected if the IC 50 for the internal Mic-LR standard did not fall within the acceptable IC 50 range previously defined for that specific batch of ELISA or protein phosphatase reagents. The PCR is a non-quantitative, presence/absence method. Two internal controls were used, firstly DNA extracted from a cyanobacterium and secondly DNA from a known mcyA producing cyanobacterium. The PCR results were rejected on the basis of low recovery if either of these internal controls was not positive.
This occurred on several occasions for the PCR analyses, particularly with samples with high concentrations of cells of mcyA producing cyanobacteria. The HPLC used a known concentration of nodularin as the internal standard.
Method performance
We ranked the performance of each method into five categories: microcystin detection limit, cost, level of analyst training required, selectivity for microcystin, and turnaround time (TAT). The adequacy of each method was first determined by whether the detection limit reported by the analytical laboratories was below the WHO guideline for microcystin (or toxigenic cell equivalents). The microscopy and PCR methods report concentration of toxigenic cells and so to compare these methods with the WHO guideline, we inter-converted between Microcystis cells and microcystin per cell by assuming each Microcystis cell contained 10 213 g microcystin (after Orr & Jones 1998).
We assigned a quantitative performance characteristic to each method in each category from our laboratory experience (i.e. cost, turnaround time). The cost estimate was restricted to consumables and equipment depreciation, because of the wide variation in labour cost internationally.
The experience required to train an analyst in the method and the selectivity of each method were assigned subjectively, based on the experience of the lab managers involved in the study.
We normalised the performance of each method within a category against the least desirable method (i.e. slowest or most costly). Therefore the lowest percentage score corresponds to the highest ranking. We then ranked those methods with adequate detection limits, by taking the mean of the normalised result for each category.
RESULTS AND DISCUSSION
The survey analysed 53 grab samples from suspected cyanobacterial blooms in 25 different water bodies. These samples were from 20 waterbodies in temperate zone Australia and five waterbodies in tropical Thailand. All samples were not analysed by all methods, because of logistical difficulties transporting them between laboratories. The breakdown of number analysed, positive results and the detection limit for each method is given in Table 2 . Microcystin concentrations ranged from the detection limit to more than 100 ug l 21 . Seven of the positive tests by ELISA or PPi were confirmed by HPLC for quality assurance.
Comparison of mcyA and microcystin assays
We supplemented the microcystin assay data from the 35 ELISA results with results from 13 additional samples tested only by PPi and compared the combined bioassay data with the detections of mcyA gene by PCR. These results are presented in Table 3 , displayed in quadrants representing varying levels of 'risk' of presence of microcystin.
The risks are defined by the presence (þ) or absence
(2) of either the mcyA gene or the toxin, microcystin. This analysis recognises two categories when the risk to public health was high (þþ): first, when the mcyA gene is present AND microcystin is present at concentrations above the WHO guideline of 1 ug l 21 (13 samples). The second 'High risk' category (2 þ ), was when the mcyA gene was not detected, but microcystin exceeded the WHO guideline.
This result would occur when microcystin was present in water but cells and DNA were absent because of loss by filtration, cell lysis or sedimentation.
There were eight samples in the 'Incipient risk' category (þ 2 ) that contained mcyA but where microcystin was below the biochemical assay detection limits. We are confident these are not PCR false positives, as toxigenic cyanobacteria were observed microscopically and the PCR test was several hundred times more sensitive than the biochemical assays.
A gene probe survey of Microcystis populations collected from Brazilian reservoirs for the mcyB gene found that toxic and non-toxic genotypes coexisted (Bittencourt-Oliveira 2003) . In such situations the public health risk is incipient, because the genetic capacity for microcystin production can exist, even though the toxic strain may be rare.
There were 24 samples in the 'No risk' category (2 2) that contained no detectable mcyA or microcystin and these samples represented about half of all the blooms. This is consistent with other reports from Australian surveys (see WHO 2003) .
Quality assurance
For quality assurance and to test the quantitation of the ELISA and PPi tests, seven samples containing toxigenic cells in which microcystin was detected by ELISA were also analysed by HPLC (Table 2 ). The quality assurance samples included duplicates of a reference material, a pure culture of a toxic
Microcystis strain (PCC7806). The results of all the methods were consistent within the respective ranges of each test.
Additional information from HPLC
HPLC is recommended as the standard method for the determination and quantitation of microcystins (Chorus & Bartram 1999) . In this study we have compared the usefulness of microscopy, PCR and two semi-quantitative microcystin assays for screening water for the risk to public health from microcystin toxicity. HPLC was used to quantify the microcystin in a limited number of samples to check on the accuracy of quantitation of the PPi and ELISA.
The results of the screening tests were unanimous in 43 of the 53 samples (Table 4 ). We reviewed the 10 results
where there was disagreement between one or more tests to determine whether an unequivocal method of toxin identification (HPLC) could have improved our understanding of the potential risk and allowed us to better reconcile apparent differences between the tests results. In the first three samples in Table 4 (samples 1 -3), the PPi and the ELISA results disagreed. In these samples, further quantitation by HPLC could have resolved this problem and confirmed the presence or absence of microcystin. In these samples, even though toxigenic cyanobacteria were identified microscopically, the absence of mcyA suggests the PPi result may have been a false positive, as these cells should not have been able to synthesise microcystin.
Inhibition of phosphatase enzyme activity by compounds
other than microcystin has been described before (e.g.
Robillot & Hennion 2004
) and a variation to the PPi method, to deactivate non-microcystin inhibitors of the protein phosphatase enzyme and improve the specificity of the test has been reported recently (Rapala et al. 2002) .
There were two other examples (samples 4 and 5) where the PPi and ELISA results disagreed. In these cases quantitation by HPLC was unlikely to have resolved this disagreement because the conflicting results were at or below the detection limit (DL) of the HPLC analysis of 0.5 ug l 21 . These two samples both contained toxigenic cells and mcyA gene, suggesting the ELISA result may have been a false negative.
There were two samples (samples 6 and 7) in which only the PCR was positive. These are samples where PCR identified an incipient risk. Although microcystin was not detectable, the DL for PCR is 10 mcyA containing cells per ml whereas the DL for ELISA, PPi and HPLC was 2,000, 3,000 and 5,000 highly toxic Microcystis cells, respectively.
In these cases HPLC cannot add more information.
The difference in result between PCR and the other three tests could not be explained satisfactorily for the results of samples 8 -10. We propose the PCR nondetection of mcyA in these samples was a false negative, because the other three tests detected high concentrations of either toxic cyanobacteria or microcystin.
The PCR protocol does include a check for inhibition of DNA amplification. Inhibition of amplification was reported in some high algal biomass samples. The chlorophyll concentration of samples 8 -10 was more than 100 ug l 21 , but there was no evidence of PCR inhibition.
Therefore these three results cast a doubt over the reliability of the PCR test at high cell concentrations. This could be addressed by standard dilution of concentrated samples.
The quantitation of microcystin in these three samples by HPLC would neither prove nor disprove the presence of the mcyA gene.
Performance ranking all methods
We ranked the overall performance of each method for detection limit and selectivity for microcystin, analytical cost, analytical skill needed and turnaround time. These rankings are offered as a qualitative measure of the relative usefulness of each method for assessing public health risk from cyanobacterial contamination of recreational or potable water supplies.
The mouse assay was excluded because it was not sufficiently sensitive to detect microcystin (or equivalent cell concentrations) below the WHO guideline level of 1 ug l 21 . PCR and microscopy were much more sensitive than the other techniques ( Table 5 ).
The rank order of the methods was usually different between categories. The chromatographic methods (LC/MS and HPLC) were the most selective (PCR although highly 
CONCLUSIONS
The ELISA test was judged best for screening environmental water samples for microcystin-like compounds because of its reliability, specificity to microcystin, low cost, high sensitivity and ease of analysis.
The PCR test was highly sensitive and the mcyA gene was detected in significantly more samples than microcystin indicating a capacity to detect situations in which public health risk was incipient. The test was also relatively cheap, but it did produce false negatives at high cell concentrations. We expect that simple improvements to the PCR and PPi protocols will significantly increase the usefulness of both these tests for environmental analysis in future.
ELISA and PPi have been recommended as useful screening techniques, when combined with more specific assays based on structural recognition of microcystin, such as HPLC or LC/MS (Robillot & Hennion 2004) . We 
